Literature DB >> 16499621

Coaggregation of Porphyromonas gingivalis and Fusobacterium nucleatum PK 1594 is mediated by capsular polysaccharide and lipopolysaccharide.

Graciela Rosen1, Michael N Sela.   

Abstract

Previous reports have shown that coaggregation between Porphyromonas gingivalis and Fusobacterium nucleatum, two important periodontopathogens, is mediated by a galactoside on the surface of P. gingivalis and a lectin on F. nucleatum. In the present study, purified capsular polysaccharide (CPS) and lipopolysaccharide (LPS) of P. gingivalis PK 1924 (serotype K5) were found to be able to bind to F. nucleatum cells and to inhibit binding of F. nucleatum to P. gingivalis serotype K5. Sugar binding studies showed that the requirements for binding of P. gingivalis serotype K5 CPS and LPS to the F. nucleatum lectin are: the presence of a metal divalent ion, an axial free hydroxyl group at position 4 and free equatorial hydroxyl groups at position 3 and 6 of d-galactose. These data suggest that P. gingivalis serotype K5- CPS and LPS act as receptors mediating coaggregation between P. gingivalis and fusobacteria.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16499621     DOI: 10.1111/j.1574-6968.2006.00131.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  19 in total

Review 1.  Bacterial interactions in dental biofilm.

Authors:  Ruijie Huang; Mingyun Li; Richard L Gregory
Journal:  Virulence       Date:  2011-09-01       Impact factor: 5.882

2.  Fap2 of Fusobacterium nucleatum is a galactose-inhibitable adhesin involved in coaggregation, cell adhesion, and preterm birth.

Authors:  S Coppenhagen-Glazer; A Sol; J Abed; R Naor; X Zhang; Y W Han; G Bachrach
Journal:  Infect Immun       Date:  2015-01-05       Impact factor: 3.441

3.  Identification of Fusobacterium nucleatum in primary and secondary endodontic infections and its association with clinical features by using two different methods.

Authors:  Brenda P F A Gomes; Juliana D Bronzato; Rebecca F Almeida-Gomes; Ericka T Pinheiro; Ezilmara L R Sousa; Rogério C Jacinto
Journal:  Clin Oral Investig       Date:  2021-04-12       Impact factor: 3.573

4.  D-Galactose as an autoinducer 2 inhibitor to control the biofilm formation of periodontopathogens.

Authors:  Eun-Ju Ryu; Jaehyun Sim; Jun Sim; Julian Lee; Bong-Kyu Choi
Journal:  J Microbiol       Date:  2016-08-31       Impact factor: 3.422

Review 5.  Microbial interactions in building of communities.

Authors:  C J Wright; L H Burns; A A Jack; C R Back; L C Dutton; A H Nobbs; R J Lamont; H F Jenkinson
Journal:  Mol Oral Microbiol       Date:  2012-12-17       Impact factor: 3.563

Review 6.  Subgingival biofilm formation.

Authors:  Masae Kuboniwa; Richard J Lamont
Journal:  Periodontol 2000       Date:  2010-02       Impact factor: 7.589

7.  FimR and FimS: biofilm formation and gene expression in Porphyromonas gingivalis.

Authors:  Alvin Lo; Christine Seers; Stuart Dashper; Catherine Butler; Glenn Walker; Katrina Walsh; Deanne Catmull; Brigitte Hoffmann; Steven Cleal; Patricia Lissel; John Boyce; Eric Reynolds
Journal:  J Bacteriol       Date:  2010-01-08       Impact factor: 3.490

8.  Characterization and development of SAPP as a specific peptidic inhibitor that targets Porphyromonas gingivalis.

Authors:  Meng-Hsuan Ho; Richard J Lamont; Walter J Chazin; Huiqing Chen; Daphne F Young; Prashant Kumar; Hua Xie
Journal:  Mol Oral Microbiol       Date:  2018-10-30       Impact factor: 3.563

Review 9.  Roles of Porphyromonas gingivalis and its virulence factors in periodontitis.

Authors:  Weizhe Xu; Wei Zhou; Huizhi Wang; Shuang Liang
Journal:  Adv Protein Chem Struct Biol       Date:  2020-01-10       Impact factor: 3.507

10.  The capsule of Porphyromonas gingivalis reduces the immune response of human gingival fibroblasts.

Authors:  Jorg Brunner; Nina Scheres; Nawal B El Idrissi; Dong M Deng; Marja L Laine; Arie J van Winkelhoff; Wim Crielaard
Journal:  BMC Microbiol       Date:  2010-01-11       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.